Berberine vs Ozempic: What the Evidence Actually Says

If you have spent any time on TikTok or in a supplement aisle since 2023, you have seen berberine sold as “nature’s Ozempic.” It is one of the most successful supplement marketing lines of the decade. It is also, on the evidence, wrong.

Berberine is not nothing. It is a genuine bioactive compound with measurable effects on blood sugar and cholesterol, and it has been studied for decades, mostly in China. But the specific claim that it does what semaglutide does, at a fraction of the price, does not survive contact with the trial data.

Here is what each one actually is, what each one actually does, and how big the gap is.

What is berberine, and where does it come from?

Berberine is a yellow alkaloid found in several plants, including barberry (Berberis species), goldenseal, Oregon grape and Coptis chinensis, a staple of traditional Chinese medicine [1]. In the United States it is sold as a dietary supplement, usually as berberine hydrochloride in 500 mg capsules.

Its main mechanism is activation of AMP-activated protein kinase, or AMPK, an enzyme that acts as a kind of cellular fuel gauge [2]. It also changes how the liver produces and processes cholesterol and triglycerides, inhibits an enzyme called PCSK9, and alters gut bacteria and nutrient absorption [2].

What it does not do is bind the GLP-1 receptor.

What is Ozempic, and how is it different?

Ozempic is the brand name for semaglutide at the doses approved for type 2 diabetes. Wegovy is the same molecule at doses approved for weight management. Semaglutide is a GLP-1 receptor agonist: a synthetic version of a gut hormone your body releases after eating [3].

When semaglutide binds the GLP-1 receptor, it slows how fast your stomach empties, increases insulin release when blood sugar is high, and acts directly on appetite centers in the brain. People describe the result as food noise going quiet.

So the first honest answer to “berberine vs Ozempic” is that they are not the same kind of thing pointed at the same target. One is a supplement that nudges a metabolic enzyme. The other is a prescription peptide drug that occupies a hormone receptor.

How much weight does berberine actually cause you to lose?

This is where the marketing and the literature part company.

A 2020 dose-response meta-analysis of 10 randomized controlled trials found that berberine significantly reduced BMI (by 0.29 kg/m²) and waist circumference (by 2.75 cm), but produced no significant change in body weight at all: a weighted mean difference of −0.11 kg, with a confidence interval running from −0.99 to +0.76 kg [4][5]. That confidence interval crossing zero is the important part. It means the data are consistent with berberine doing nothing to your weight.

A 2022 dose-response meta-analysis in Frontiers in Nutrition was slightly more favorable, reporting −0.84 kg for weight and −0.25 kg/m² for BMI. But the authors graded the evidence as only moderate quality and flagged a “high serious limitation” for risk of bias in the underlying studies [6]. Subgroup analysis found the effect was only significant in people in the overweight BMI range of 25 to 29.9, and that category simply had three times as many trials as the obese and normal-weight categories combined [6].

More recent pooled analyses, including a 2025 systematic review in the International Journal of Obesity, continue to report reductions in BMI and waist circumference [7].

The US Department of Defense’s Operation Supplement Safety program put it most bluntly. Reviewing the same literature, it noted that one review reported a weight reduction of 0.84 kg, “almost 2 lbs,” in people with certain diseases after up to 18 weeks. But “when low quality studies are excluded, this reported reduction in weight no longer” holds [8]. Its overall conclusion: “the evidence does not support claims for berberine as the ‘key to weight loss’” [8].

UCLA Health’s assessment is similar: most experts agree the amount of weight you can lose with berberine is unclear and the evidence is inconclusive [1]. The American Academy of Family Physicians has published under the headline that the berberine weight-loss fad “lacks rigorous evidence” and “has potential harms” [9].

How much weight does semaglutide cause you to lose?

In STEP 1, the pivotal trial for Wegovy, 1,961 adults were randomized 2:1 to semaglutide 2.4 mg or placebo for 68 weeks. Mean weight change was −14.9% on semaglutide versus −2.4% on placebo, an estimated treatment difference of 12.4 percentage points (95% CI −13.4 to −11.5, P<0.001) [18].

In SURMOUNT-5, a head-to-head trial against tirzepatide published in the New England Journal of Medicine, semaglutide produced a least-squares mean weight reduction of 13.7% at 72 weeks, equal to 15.0 kg, or about 33 pounds [10].

Put the two side by side:

	Berberine	Semaglutide (Wegovy)
Mean weight change	0 to −0.84 kg (0 to ~2 lbs)	−15.0 kg (~33 lbs)
Trial length	8–18 weeks	68–72 weeks
Evidence quality	Moderate at best; high risk of bias flagged	Large, pre-registered, regulator-reviewed phase 3 program
Regulatory status	Dietary supplement, no FDA pre-market review	FDA-approved prescription drug

That is not a close comparison. It is roughly a 15-to-40-fold difference, depending on which berberine meta-analysis you pick.

So is berberine useless?

No, and this is where a lot of debunking articles overcorrect.

Berberine’s best evidence is not for weight. It is for blood sugar and lipids.

In a 2008 pilot study published in Metabolism, 36 adults with newly diagnosed type 2 diabetes were randomized to berberine 500 mg three times daily or metformin 500 mg three times daily for three months. The hypoglycemic effect of berberine was similar to metformin’s, with significant decreases in HbA1c, fasting glucose and postprandial glucose [11]. On lipids, berberine actually outperformed metformin: by week 13, triglycerides and total cholesterol were significantly lower in the berberine group [11].

Later meta-analyses have supported the glucose and lipid findings. Berberine significantly lowers triglycerides, and improves LDL and HDL cholesterol in people whose levels are abnormal [1].

That is a real and useful pharmacological profile. It is just not a weight-loss profile, and it is not a reason to skip a prescribed medication. As one review summarized it: berberine is a metabolic-support supplement that may help some people a little, especially where insulin resistance is part of the picture.

What are the real risks of taking berberine?

Three things matter here, and the third is the one people underestimate.

Digestive side effects. Nausea, upset stomach, constipation, diarrhea, cramping and rash are the common ones [12].

Liver. The NIH’s LiverTox database gives berberine a likelihood score of E, meaning it is an unlikely cause of clinically apparent liver injury, and notes that in published trials it has been well tolerated with adverse effects similar in frequency to placebo [13]. That is reassuring, with the caveat that few prospective human studies have reported on laboratory results in detail.

Drug interactions. This is the underrated risk. Berberine inhibits the CYP2D6, CYP3A4 and CYP2C9 liver enzymes and several drug transporters that clear medicines from your body [12]. By slowing those pathways, it can raise blood levels of drugs you are already taking at their normal doses. Poison Control describes a case in which a 68-year-old man was hospitalized with jaundice and liver damage after three weeks of berberine alongside his regular prescriptions, including the blood thinner rivaroxaban. He was found to have an abnormally high rivaroxaban level, which his doctors believed was caused by a berberine interaction. He recovered after stopping berberine [14].

Because the size of any interaction depends on how each specific drug is cleared, this has to be checked medicine by medicine with a pharmacist or prescriber. It is not something to guess at.

Long-term safety is simply unknown. Most trials are three to six months. Poison Control and the NIH’s LiverTox both note that berberine is not considered safe in pregnancy or for newborns, and LiverTox records that berberine can displace bilirubin in newborns [13][14]. That is a stated contraindication in those references, not general advice about what anyone should take.

Does the berberine in the bottle match the label?

Often, but not always. ConsumerLab tested 10 berberine and goldenseal products and reported in September 2023 that nearly 45% of the products selected had problems [15]. Five of six berberine supplements passed, though one was short on berberine. All three goldenseal products failed: one contained almost none of the expected berberine, and two were contaminated with lead [15].

Goldenseal is the higher-risk form, because berberine in it is naturally occurring rather than added at a measured dose. The relevant regulatory fact is that the FDA does not review or test supplements for content or potency before they go on sale, so a third-party verification mark (USP, NSF, ConsumerLab, Informed Choice) is the only independent check most buyers have on whether the label matches the capsule.

Why did berberine get the “nature’s Ozempic” nickname at all?

Three things lined up in 2023.

Semaglutide demand exploded while supply, insurance coverage and price all became barriers. Berberine had a genuine, if modest, published effect on metabolic markers, which gave the claim a kernel of truth to build on. And social media rewards a short, sticky comparison far more than it rewards a confidence interval.

The result is a claim that is technically anchored to something real and practically misleading. Berberine does affect metabolism. It does not do what the drug does.

What should you do with this?

If you were considering berberine specifically to replace a GLP-1 drug, the evidence does not support that swap, and you should know that going in.

If you are interested in it for blood sugar or cholesterol, that is a more defensible reason, and it is worth raising with your healthcare provider along with a list of everything else you take, because of the interaction issue.

If cost is what pushed you toward supplements in the first place, it is worth knowing the price of the approved options before you spend $15 to $40 a month on berberine. Generic phentermine averages about $37 to $41 for a month’s supply and can be as low as roughly $14 with a coupon where state law allows it [16]. Generic phentermine/topiramate ER, which produced around 10% weight loss in its trials, runs roughly $59 to $63 a month with a coupon. If you already have a primary care visit scheduled, raising weight treatment at that visit generally costs nothing extra beyond the visit itself, though whether a specific drug is appropriate, and what it will cost you, depends on your history and your coverage.

And if you take nothing else from this: The Obesity Society’s systematic review screened more than 20,000 citations and analyzed 315 randomized trials of weight-loss supplements and alternative therapies. Only 52 were low risk of bias and sufficient to support efficacy. Of those, only 16 showed a significant weight difference versus placebo, ranging from 0.3 to 4.93 kg [17]. Sixteen out of 315 is the real base rate for this entire category, and berberine is one of its better-studied members.

This article summarizes what published studies, FDA-approved labeling and reference sources report. It is not medical advice and does not recommend any dose or product. Follow your own prescription and the directions your prescriber and pharmacist give you, and talk to a healthcare provider before starting or stopping anything, including a supplement, especially if you take prescription medicines.

Sources

1. UCLA Health — What to know about berberine, the so-called “nature’s Ozempic”: https://www.uclahealth.org/news/article/what-know-about-berberine-so-called-natures-ozempic
2. Drugs.com — What is berberine used for?: https://www.drugs.com/medical-answers/berberine-3569378
3. Eli Lilly investor release — SURMOUNT-5 complete results: https://investor.lilly.com/news-releases/news-release-details/zepbound-tirzepatide-showed-superior-weight-loss-over-wegovy
4. Asbaghi O et al. — The effect of berberine supplementation on obesity indices: a dose-response meta-analysis: https://www.sciencedirect.com/science/article/abs/pii/S1744388119303871
5. PubMed record for the same meta-analysis: https://pubmed.ncbi.nlm.nih.gov/32379652
6. Frontiers in Nutrition — Berberine supplementation and cardiovascular risk factors: systematic review and dose-response meta-analysis: https://www.frontiersin.org/journals/nutrition/articles/10.3389/fnut.2022.1013055/full
7. International Journal of Obesity — The effect of berberine on obesity indices: systematic review and meta-analysis: https://www.nature.com/articles/s41366-025-01943-x
8. Operation Supplement Safety (US Department of Defense) — Berberine: the hype for “nature’s Ozempic”: https://www.opss.org/article/berberine-hype-natures-ozempic
9. American Academy of Family Physicians — Weight loss fad berberine lacks rigorous evidence, has potential harms: https://www.aafp.org/afp/afp-community-blog/weight-loss-fad-berberine-natures-ozempic-lacks-rigorous-evidence-has-potential-harms
10. Aronne LJ et al., NEJM 2025 — Tirzepatide as compared with semaglutide (SURMOUNT-5): https://investor.lilly.com/news-releases/news-release-details/zepbound-tirzepatide-showed-superior-weight-loss-over-wegovy
11. Yin J, Xing H, Ye J, Metabolism 2008 — Efficacy of berberine in patients with type 2 diabetes: https://pmc.ncbi.nlm.nih.gov/articles/PMC2410097
12. Drugs.com — Berberine drug interactions: https://www.drugs.com/medical-answers/berberine-3569378
13. NIH LiverTox — Berberine: https://www.ncbi.nlm.nih.gov/books/NBK564659
14. Poison Control — What are the benefits of berberine?: https://www.poison.org/articles/berberine
15. ConsumerLab — Berberine and goldenseal supplements review: https://www.consumerlab.com/berberine
16. GoodRx — How much does phentermine cost with and without insurance: https://www.goodrx.com/phentermine/phentermine-cost-for-weight-loss
17. Batsis JA et al., Obesity 2021;29(7):1102-1113 — A systematic review of dietary supplements and alternative therapies for weight loss: https://pubmed.ncbi.nlm.nih.gov/34159755
18. Wilding JPH et al., N Engl J Med 2021;384(11):989-1002 — Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1, NCT03548935): https://pubmed.ncbi.nlm.nih.gov/33567185